-
Je něco špatně v tomto záznamu ?
Serum Bilirubin Concentrations and the Prevalence of Gilbert Syndrome in Elite Athletes
J. Woronyczová, M. Nováková, M. Leníček, M. Bátovský, E. Bolek, R. Cífková, L. Vítek
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
MH CZ-DRO-VFN64165
Ministerstvo Zdravotnictví Ceské Republiky
SVV 260156/2021
Univerzita Karlova v Praze
Progres Q25/LF1
Univerzita Karlova v Praze
NLK
Directory of Open Access Journals
od 2015
PubMed Central
od 2015
Europe PubMed Central
od 2015
ProQuest Central
od 2018-06-01
Open Access Digital Library
od 2015-01-01
Open Access Digital Library
od 2015-01-01
Nursing & Allied Health Database (ProQuest)
od 2018-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2015
Springer Journals Complete - Open Access
od 2015-12-01
Springer Nature OA/Free Journals
od 2015-12-01
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: Bilirubin is a potent endogenous antioxidant and immunomodulating substance, which is also implicated in both cell signalling and various metabolic pathways. Mild elevation of systemic bilirubin concentrations provides substantial protection against many diseases of civilization. Rare published reports have suggested that serum bilirubin might also be relevant to sports performance. The purpose of the current study was to evaluate serum bilirubin concentrations and the prevalence of Gilbert syndrome (GS) in elite athletes. METHODS: The study was carried out in 536 consecutive healthy elite athletes and in 2594 individuals of the Czech post-MONICA study representing the general Czech population. Serum bilirubin concentrations, the prevalence of benign hyperbilirubinemia > 17 μmol/L (1 mg/dL, a phenotypic sign of GS), and a variant of the UGT1A1 gene promoter responsible for GS manifestation in Caucasians (rs81753472) were evaluated in study subjects. RESULTS: Compared to the general Czech population, significantly higher serum bilirubin concentrations were found in elite athletes (9.6 vs. 11.6 μmol/L, p < 0.001), both in men (11.3 vs. 12.6 μmol/L, p < 0.001) and women (8.3 vs. 10.5 μmol/L, p < 0.001). Furthermore, the prevalence of GS was also significantly higher in elite athletes (9.6 vs. 22%, p < 0.001) together with the tendency to higher frequencies of the genotypes (TA)7/7 and (TA)6/7 UGT1A1. CONCLUSION: Elite athletes have significantly higher concentrations of serum bilirubin, the most potent endogenous antioxidant substance known. Simultaneously, the prevalence of GS syndrome is also much higher in elite athletes, suggesting that a mild elevation of serum bilirubin might predispose to better sports performance.
Slovak Army Sport Centre Dukla Banská Bystrica Banská Bystrica Slovak Republic
Sports Research Institute of the Czech Armed Forces Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22016942
- 003
- CZ-PrNML
- 005
- 20220720100039.0
- 007
- ta
- 008
- 220718s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s40798-022-00463-6 $2 doi
- 035 __
- $a (PubMed)35759151
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Woronyczová, Jana $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital in Prague and 1st Faculty of Medicine, Charles University, Na Bojišti 3, Praha 2, 12000, Prague, Czech Republic $u Sports Research Institute of the Czech Armed Forces, Prague, Czech Republic
- 245 10
- $a Serum Bilirubin Concentrations and the Prevalence of Gilbert Syndrome in Elite Athletes / $c J. Woronyczová, M. Nováková, M. Leníček, M. Bátovský, E. Bolek, R. Cífková, L. Vítek
- 520 9_
- $a OBJECTIVES: Bilirubin is a potent endogenous antioxidant and immunomodulating substance, which is also implicated in both cell signalling and various metabolic pathways. Mild elevation of systemic bilirubin concentrations provides substantial protection against many diseases of civilization. Rare published reports have suggested that serum bilirubin might also be relevant to sports perfo $a OBJECTIVES Bilirubin is a potent endogenous antioxidant and immunomodulating substance which is also implicated in both cell signalling and various metabolic pathways Mild elevation of systemic bilirubin concentrations provides substantial protection against many diseases of civilization Rare published reports have suggested that serum bilirubin might also be relevant to sports performan $a OBJECTIVES: Bilirubin is a potent endogenous antioxidant and immunomodulating substance, which is also implicated in both cell signalling and various metabolic pathways. Mild elevation of systemic bilirubin concentrations provides substantial protection against many diseases of civilization. Rare published reports have suggested that serum bilirubin might also be relevant to sports performance. The purpose of the current study was to evaluate serum bilirubin concentrations and the prevalence of Gilbert syndrome (GS) in elite athletes. METHODS: The study was carried out in 536 consecutive healthy elite athletes and in 2594 individuals of the Czech post-MONICA study representing the general Czech population. Serum bilirubin concentrations, the prevalence of benign hyperbilirubinemia > 17 μmol/L (1 mg/dL, a phenotypic sign of GS), and a variant of the UGT1A1 gene promoter responsible for GS manifestation in Caucasians (rs81753472) were evaluated in study subjects. RESULTS: Compared to the general Czech population, significantly higher serum bilirubin concentrations were found in elite athletes (9.6 vs. 11.6 μmol/L, p < 0.001), both in men (11.3 vs. 12.6 μmol/L, p < 0.001) and women (8.3 vs. 10.5 μmol/L, p < 0.001). Furthermore, the prevalence of GS was also significantly higher in elite athletes (9.6 vs. 22%, p < 0.001) together with the tendency to higher frequencies of the genotypes (TA)7/7 and (TA)6/7 UGT1A1. CONCLUSION: Elite athletes have significantly higher concentrations of serum bilirubin, the most potent endogenous antioxidant substance known. Simultaneously, the prevalence of GS syndrome is also much higher in elite athletes, suggesting that a mild elevation of serum bilirubin might predispose to better sports performance.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Nováková, Miroslava $u Sports Research Institute of the Czech Armed Forces, Prague, Czech Republic
- 700 1_
- $a Leníček, Martin $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital in Prague and 1st Faculty of Medicine, Charles University, Na Bojišti 3, Praha 2, 12000, Prague, Czech Republic
- 700 1_
- $a Bátovský, Miloš $u Slovak Army Sport Centre Dukla Banská Bystrica, Banská Bystrica, Slovak Republic
- 700 1_
- $a Bolek, Emil $u Sports Research Institute of the Czech Armed Forces, Prague, Czech Republic
- 700 1_
- $a Cífková, Renata $u Center for Cardiovascular Prevention, 1st Faculty of Medicine, Charles University, and Thomayer University Hospital, Prague, Czech Republic
- 700 1_
- $a Vítek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital in Prague and 1st Faculty of Medicine, Charles University, Na Bojišti 3, Praha 2, 12000, Prague, Czech Republic. vitek@cesnet.cz $u 4th Department of Internal Medicine, General University Hospital in Prague and 1st Faculty of Medicine,, Charles University, Prague, Czech Republic. vitek@cesnet.cz $1 https://orcid.org/0000000253180151 $7 xx0035071
- 773 0_
- $w MED00209358 $t Sports medicine - open $x 2199-1170 $g Roč. 8, č. 1 (2022), s. 84
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35759151 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20220720100034 $b ABA008
- 999 __
- $a ind $b bmc $g 1816380 $s 1168184
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 8 $c 1 $d 84 $e 20220627 $i 2199-1170 $m Sports medicine - open $n Sports Med Open $x MED00209358
- GRA __
- $a MH CZ-DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a SVV 260156/2021 $p Univerzita Karlova v Praze
- GRA __
- $a Progres Q25/LF1 $p Univerzita Karlova v Praze
- LZP __
- $a Pubmed-20220718